COMMUNIQUÉS West-GlobeNewswire

Johnson & Johnson receives positive CHMP opinion for RYBREVANT®▼ (amivantamab) in combination with chemotherapy for the first-line treatment of patients with advanced non-small cell lung cancer with activating EGFR exon 20 insertion mutations
26/04/2024
This positive CHMP opinion establishes amivantamab as a new option, and the first fully-human EGFR-MET bispecific antibody, in the first-line treatment of EGFR exon 20 insertion-mutated NSCLC The recommendation is [...]
Apellis Announces Pegcetacoplan MAA Review Has Been Reset to Day 180 of Initial Assessment by European Medicines Agency (EMA)
26/04/2024
Decision by EMA follows recent judgment by the Court of Justice of the European Union regarding the organization of EMA’s expert groups Apellis anticipates a CHMP opinion no later than July 2024 WALTHAM, Mass., April 26 [...]
Y-mAbs to Announce First Quarter 2024 Financial and Operating Results on May 7, 2024
26/04/2024
The Company will host a conference call and webcast on Wednesday, May 8, 2024 at 8:00 a.m. ET NEW YORK, April 26, 2024 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB) today [...]
Krystal Biotech to Report First Quarter 2024 Financial Results on May 6, 2024
26/04/2024
PITTSBURGH, April 26, 2024 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company, today announced that it will report its first quarter 2024 financial results [...]
Interactive Strength Inc. (Nasdaq: TRNR) Strengthens Balance Sheet by Partially Converting Senior Loan to Equity and Extending the Maturity
26/04/2024
Reduced the Liability of the Senior Loan by Converting $3.0 Million to Equity Extended the Maturity of the Remaining Balance to December 2024 AUSTIN, TX, April 26, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – Interactive [...]
Ocugen to Present on Modifier Gene Therapy Platform at Association for Research in Vision and Ophthalmology 2024 Annual Meeting
26/04/2024
MALVERN, Pa., April 26, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, and [...]
Novo Nordisk A/S – Total number of voting rights and share capital in Novo Nordisk A/S as of 26 April 2024
26/04/2024
Bagsværd, Denmark, 26 April 2024 – In accordance with Section 32 of the Danish Capital Markets Act, Novo Nordisk A/S is required to publish the total number of voting rights and the size of the share capital in Novo [...]
The Ensign Group Schedules First Quarter Earnings Call for Thursday, May 2, 2024
26/04/2024
SAN JUAN CAPISTRANO, Calif., April 26, 2024 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign TM group of companies, which invest in and provide skilled nursing and senior [...]
Composition of the Nomination Committee of Orion Corporation
26/04/2024
ORION CORPORATION STOCK EXCHANGE RELEASE – OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE 26 APRIL 2024 at 11.15 EEST Composition of the Nomination Committee of Orion Corporation The Board of [...]
Medigene AG reports Financial Results and Business Update for Q1 2024
26/04/2024
Planegg/Martinsried, April 26, 2024. Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid [...]
PCI Biotech Holding ASA - Annual Report 2023
26/04/2024
Oslo, Norway, April 26, 2024. The Board of Directors of PCI Biotech Holding ASA has approved the Annual Report 2023. Please find the report attached, as well as the report according to the European Single Electronic [...]
Nexstim Plc Business Update Q1 2024
26/04/2024
Press release, Helsinki, 26 April 2024 at 9 AM (EEST) Nexstim Plc Business Update Q1 2024 Nexstim Plc (NXTMH:HEX) (”Nexstim” or ”Company”) announces the key highlights of the Company’s business operations during Q1 2024 [...]
Burning Rock Announces ADS Ratio Change
26/04/2024
GUANGZHOU, China, April 26, 2024 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing (NGS) [...]
JERAYGO (aprocitentan) recommended for approval in Europe for the treatment of resistant hypertension
26/04/2024
Ad hoc announcement pursuant to Art. 53 LR Idorsia receives a positive opinion from the Committee for Medicinal Products for Human Use for JERAYGO™ (aprocitentan) as the first and only endothelin receptor antagonist for [...]
Vincerx Pharma Announces Pricing of Underwritten Public Offering of Common Stock and Warrants
26/04/2024
PALO ALTO, Calif., April 25, 2024 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC) today announced the pricing of an underwritten public offering of (i) 6,000,000 shares of its common stock and accompanying [...]
Belite Bio Announces $25 Million Registered Direct Offering
26/04/2024
SAN DIEGO, April 25, 2024 (GLOBE NEWSWIRE) -- Belite Bio , Inc (NASDAQ: BLTE) (“Belite Bio” or the “Company”), a clinical-stage biopharmaceutical drug development company focused on advancing novel therapeutics [...]
Intuitive Announces Board of Directors Elections and Retirements
26/04/2024
Lewis Chew elected to Intuitive’s Board Alan Levy, PhD and Don Kania, PhD to retire from Board SUNNYVALE, Calif., April 25, 2024 (GLOBE NEWSWIRE) -- Intuitive (Nasdaq: ISRG), a global technology leader in minimally [...]
Altimmune Statement on the Passing of Dr. Stephen Harrison
25/04/2024
GAITHERSBURG, Md., April 25, 2024 (GLOBE NEWSWIRE) -- The Altimmune team would like to express our sorrow and extend our heartfelt condolences to Dr. Stephen Harrison’s family following his tragic and unexpected passing [...]
Aesthetic Medical International Holdings Group Ltd. Announces Receipt of Decision from the Nasdaq Hearings Panel for Conditional Continued Listing
25/04/2024
Shenzhen, China, April 25, 2024 (GLOBE NEWSWIRE) -- Aesthetic Medical International Holdings Group Limited (Nasdaq: AIH) (the “Company” or “AIH”), a leading provider of aesthetic medical services in China, today [...]

Pages